Analystreport

Pluristem Therapeutics Inc. (NASDAQ: PSTI) had its price target lowered by analysts at Alliance Global Partners from $9.50 to $4.00.

Pluristem Therapeutics, Inc.  (PSTI) 
Last pluristem therapeutics, inc. earnings: 2/6 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: pluristem.com